SEARCH RESULTS for assignee:"BRISTOL-MYERS SQUIBB COMPANY"

Showing 1 to 20 of 82 results

Last Update Patent(s) Assignor(s) Orig. Assignee(s) Assignee(s) Reel/Frame
14-Jun-2018

(X0) 1: INHIBITORS OF TYPE 2 VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTORS

(A1) 2: INHIBITORS OF TYPE 2 VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTORS

CHEN, YAN

GETMANOVA, ELENA

WRIGHT, MARTIN C.

HARRIS, ALAN S.

LIM, AI CHING

GOKEMEIJER, JOCHEM

SUN, LIN

WITTEKIND, MICHAEL

BRISTOL-MYERS SQUIBB COMPANY

45122/200

14-Jun-2018

(X0) 1: FACTOR XIA MACROCYCLES WITH NOVEL P1 GROUPS

(A1) 2: FACTOR XIA MACROCYCLES WITH NOVEL P1 GROUPS

CORTE, JAMES R.

DILGER, ANDREW K.

EWING, WILLIAM R.

PINTO, DONALD J.P.

YANG, WU

BRISTOL-MYERS SQUIBB COMPANY

45475/360

14-Jun-2018

(X0) 1: ANTI-GITR ANTIBODIES FOR CANCER DIAGNOSTICS

(A1) 2: ANTI-GITR ANTIBODIES FOR CANCER DIAGNOSTICS

WANG, XI-TAO

ADELAKUN, OLUFEMI A.

LEWIN, ANNE C.

KORMAN, ALAN J.

SELBY, MARK J.

WANG, CHANGYU

HUANG, HAICHUN

HENNING, KARLA A.

LONBERG, NILS

SRINIVASAN, MOHAN

HAN, MICHELLE MINHUA

CHEN, GUODONG

HUANG, RICHARD Y.

CHAKRABORTY, INDRANI

WONG, SUSAN CHIEN-SZU

LI, HUIMING

BRISTOL-MYERS SQUIBB COMPANY

45954/580

29-May-2018

(X0) 1: GDF-8 Inhibitors

(A1) 2: GDF-8 Inhibitors

(B2) 9: GDF-8 Inhibitors

VELAPARTHI, UPENDER

BORZILLERI, ROBERT M.

BRISTOL-MYERS SQUIBB COMPANY

38725/990

29-May-2018

(X0) 1: GDF-8 Inhibitors

(A1) 2: GDF-8 Inhibitors

(B2) 9: GDF-8 Inhibitors

BRISTOL-MYERS SQUIBB COMPANY

38725/971

29-May-2018

(X0) 1: GDF-8 Inhibitors

(A1) 2: GDF-8 Inhibitors

(B2) 9: GDF-8 Inhibitors

VELAPARTHI, UPENDER

BORZILLERI, ROBERT M.

BRISTOL-MYERS SQUIBB COMPANY

39768/38

29-May-2018

(X0) 1: GDF-8 Inhibitors

(A1) 2: GDF-8 Inhibitors

(B2) 9: GDF-8 Inhibitors

BRISTOL-MYERS SQUIBB COMPANY

39768/68

28-May-2018

(X0) 1: USE OF IMMUNE CHECKPOINT INHIBITORS IN CENTRAL NERVOUS SYSTEMS NEOPLASMS

(A1) 2: USE OF IMMUNE CHECKPOINT INHIBITORS IN CENTRAL NERVOUS SYSTEMS NEOPLASMS

CORIC, VLADIMIR

CHENG, SHINTA

BRISTOL-MYERS SQUIBB COMPANY

45908/79

24-May-2018

(X0) 1: COMPOSITIONS MONOVALENT FOR CD28 BINDING AND METHODS OF USE

(A1) 2: COMPOSITIONS MONOVALENT FOR CD28 BINDING AND METHODS OF USE

MCKINNON, MURRAY

NADLER, STEVEN G.

SUCHARD, SUZANNE J.

CLASSON, BRENDAN

BRISTOL-MYERS SQUIBB COMPANY

44627/298

22-May-2018

BRISTOL-MYERS SQUIBB COMPANY

40725/854

15-May-2018

(X0) 1: OXOLUPENE DERIVATIVES

(A1) 2: OXOLUPENE DERIVATIVES

(B2) 9: OXOLUPENE DERIVATIVES

REGUEIRO-REN, ALICIA

LIU, ZHENG

SWIDORSKI, JACOB

MEANWELL, NICHOLAS A.

BRISTOL-MYERS SQUIBB COMPANY

42235/842

11-May-2018

(X0) 1: CANCER IMMUNOTHERAPY BY DISRUPTING PD-1/PD-L1 SIGNALING

(A1) 2: CANCER IMMUNOTHERAPY BY DISRUPTING PD-1/PD-L1 SIGNALING

COGSWELL, JOHN P.

GOLDBERG, STACIE M.

GUPTA, ASHOK K.

JURE-KUNKEL, MARIA

WANG, XI-TAO

WIGGINTON, JON M.

BRISTOL-MYERS SQUIBB COMPANY

45762/37

10-May-2018

(X0) 1: TRICYCLIC SULFONES AS ROR GAMMA MODULATORS

(A1) 2: TRICYCLIC SULFONES AS ROR GAMMA MODULATORS

MARCOUX, DAVID

BERTRAND, MYRA BEAUDOIN

DHAR, T.G. MURALI

YANG, MICHAEL G.

XIAO, ZILI

XIAO, HAI-YUN

ZHU, YEHENG

WEIGELT, CAROLYN A.

BATT, DOUGLAS G.

BRISTOL-MYERS SQUIBB COMPANY

44262/54

10-May-2018

(X0) 1: TGF-Beta Inhibitors

(A1) 2: TGF-Beta Inhibitors

BORZILLERI, ROBERT M.

VELAPARTHI, UPENDER

LIU, PEIYING

DARNE, CHETAN

BRISTOL-MYERS SQUIBB COMPANY

44534/738

10-May-2018

(X0) 1: TGF-Beta Inhibitors

(A1) 2: TGF-Beta Inhibitors

BRISTOL-MYERS SQUIBB COMPANY

44534/805

10-May-2018

(X0) 1: ANTIBODIES AGAINST CD73 AND USES THEREOF

(A1) 2: ANTIBODIES AGAINST CD73 AND USES THEREOF

LONBERG, NILS

KORMAN, ALAN J.

BARNHART, BRYAN C.

YAMNIUK, AARON P.

SRINIVASAN, MOHAN

HENNING, KARLA A.

LEI, MING

SEGA, EMANUELA

GOODENOUGH, ANGELA

JURE-KUNKEL, MARIA N.

CHEN, GUODONG

SACK, JOHN S.

HUANG, RICHARD

CORBETT, MARTIN J.

MYERS, JOSEPH E., JR.

SCHWEIZER, LIANG

HATCHER, SANDRA V.

BRISTOL-MYERS SQUIBB COMPANY

45074/690

10-May-2018

(X0) 1: ANTIBODIES AGAINST CD73 AND USES THEREOF

(A1) 2: ANTIBODIES AGAINST CD73 AND USES THEREOF

HUANG, HAICHUN

ZHANG, PINGPING

BRISTOL-MYERS SQUIBB COMPANY

45074/736

26-Apr-2018

(X0) 1: CONTROL UNIT ASSEMBLY

(A1) 2: CONTROL UNIT ASSEMBLY

TABRON, IAN STEWART

BONNEFIN, WAYNE LEE

LINNANE, PATRICK GERRARD

LOOF, STEFAN

BERGENS, THOMAS

BAKER, TROY A.

WILSON, GRAHAM PETER

TUCKER, CARL ESTCOURT

BRISTOL-MYERS SQUIBB COMPANY

44838/25

26-Apr-2018

(X0) 1: ANTIPROLIFERATIVE COMPOUNDS AND CONJUGATES MADE THEREFROM

(A1) 2: ANTIPROLIFERATIVE COMPOUNDS AND CONJUGATES MADE THEREFROM

MCDONALD, IVAR M.

SIVAPRAKASAM, PRASANNA

IWUAGWU, CHRISTIANA I.

PEESE, KEVIN M.

CHENG, HENG

CHOWDARI, NAIDU S.

GANGWAR, SANJEEV

BRISTOL-MYERS SQUIBB COMPANY

45231/319

20-Apr-2018

(X0) 1: SERUM ALBUMIN-BINDING FIBRONECTIN TYPE III DOMAINS

(A1) 2: SERUM ALBUMIN-BINDING FIBRONECTIN TYPE III DOMAINS

MITCHELL, TRACY S.

GOSSELIN, MICHAEL L.

LIPOVSEK, DASA

PARKER, REX

CAMPHAUSEN, RAY

DAVIS, JONATHAN

FABRIZIO, DAVID

BRISTOL-MYERS SQUIBB COMPANY

45589/30